ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,950Medicare Part D Prescriptions Filled, Including Refills

Rank: 261 out of 1692

$655K Total Retail Price of All Prescriptions

Rank: 127 out of 1692

668 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 668 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 7,219 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
LEVOTHYROXINE SODIUM 434 381 1 4
SIMVASTATIN 434 373 1 1
AMLODIPINE BESYLATE 288 265 3 3
METFORMIN HCL 268 209 4 8
HYDROCODONE-ACETAMINOPHEN 221 205 S3 5 6
ALLOPURINOL 163 148 6 30
PRAVASTATIN SODIUM 161 140 7 12
HYDROCHLOROTHIAZIDE 156 129 8 9
BENAZEPRIL-HYDROCHLOROTHIAZIDE 144 115 9 177
ZOLPIDEM TARTRATE 140 102 10 23
BENAZEPRIL HCL 140 123 10 69
FUROSEMIDE 134 100 12 7
OMEPRAZOLE 133 101 13 5
LISINOPRIL 131 97 14 2
TRAMADOL HCL 115 83 15 16
CARVEDILOL 113 93 16 24
ATENOLOL 113 100 16 15
METOPROLOL TARTRATE 97 77 18 10
MELOXICAM 94 56 19 41
ZOSTAVAX 92 88 20 80
GLIMEPIRIDE 87 86 21 32
CYCLOBENZAPRINE HCL 81 44 R 22 54
AMOXICILLIN 81 70 22 95
LOSARTAN POTASSIUM 80 80 24 17
AZITHROMYCIN 80 63 24 34
SYNTHROID 80 70 24 59
WARFARIN SODIUM 80 78 24 14
LOSARTAN-HYDROCHLOROTHIAZIDE 78 73 28 38
LISINOPRIL-HYDROCHLOROTHIAZIDE 75 58 29 19
CRESTOR 73 70 30 26
ATORVASTATIN CALCIUM 72 61 31 11
SERTRALINE HCL 71 45 32 22
SPIRIVA 71 36 32 44
PANTOPRAZOLE SODIUM 68 34 34 39
GABAPENTIN 65 49 35 13
TAMSULOSIN HCL 65 55 35 31
DICLOFENAC SODIUM 64 59 37 75
ESTRADIOL 62 48 R 38 227
CLOPIDOGREL 61 46 39 43
CITALOPRAM HBR 61 49 39 21
MIRTAZAPINE 60 59 41 53
BYSTOLIC 59 47 42 129
TRAZODONE HCL 58 41 43 33
PROAIR HFA 56 37 44 40
NAMENDA 51 51 45 50
CEPHALEXIN 50 33 46 89
NEXIUM 50 38 46 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.